Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
The prior authorization for Medicare patients requires: Documentation of cardiovascular disease (hospital discharge summary, catheterization report, imaging, or cardiology consultation note) BMI documented within past 30 days Prescriber attestation that the medication is being prescribed for cardiovascular risk reduction, not weight loss The distinction is semantic
The patient reported high satisfaction with the treatment outcome (Table 1)
Important Notice: This product is intended strictly for research purposes only
Nausea is the most commonly reported issue, especially in the first weeks of treatment
Clearly, the added benefits are welcome news, he explained
In my view, the economics of the Canadian market is purely an information-gathering exercise in how a Western market responds to generic GLP-1s
